Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bioasis Technologies Inc. > BTI:TSXV; BIOAF:OTCQB - Aposense Research Collaboration
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(331)
•••
Comment by regardlesson Mar 31, 2021 7:01pm
165 Views
Post# 32919709

RE:RE:BTI:TSXV; BIOAF:OTCQB - Aposense Research Collaboration

RE:RE:BTI:TSXV; BIOAF:OTCQB - Aposense Research CollaborationLook it's good news for
sure it's just not what we expected as far as results and deals 
im frustrated I have too many shares amd have been here too long 
hey one way to look at things is there is yet to be an negative news release since I've been here ...

betyer that way then a negative one ....
hoping a deal
for some more cash comes soon and hoping that the ceo is trying her best to get those results amd deals that we have all
been waiting for 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities